| | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide|化合物GSK503 基本信息 更多信息 |
| 中文名稱: | 化合物GSK503 | | 中文同義詞: | N-[(4,6-二甲基-2-氧代-1,2-二氫-3-吡啶基)甲基]-3-甲基-1-(異丙基)-6-[6-(4-甲基-1-哌嗪基)-3-吡啶基]-1H-吲哚-4-甲酰胺;EZH2甲基轉(zhuǎn)移酶抑制劑(GSK503);化合物GSK503;GSK503,EZH2甲基轉(zhuǎn)移酶抑制劑;N-((4,6-二甲基-2-氧代-1,2-二氫吡啶-3-基)甲基)-1-異丙基-3-甲基-6-(6-(4-甲基哌嗪-1-基)吡啶-3-基)-1H-吲哚-4-甲酰胺;GSK503,EZH2 METHYLTRANSFERASE抑制劑;化合物GSK503,10 MM DMSO 溶液 | | 英文名稱: | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide | | 英文同義詞: | N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide;GSK503;GSK03;GSK-503,EZH2 inhibitor;N-[(4,6-Dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide;1H-Indole-4-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-(1-methylethyl)-6-[6-(4-methyl-1-piperazinyl)-3-pyridinyl]-;CS-1698;GSK-503;GSK 503 | | CAS號: | 1346572-63-1 | | 分子式: | C31H38N6O2 | | 分子量: | 526.67 | | EINECS號: | |  |
|
| 按國家瀏覽N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide國外供應(yīng)商 |
中國供應(yīng)商 |
|
N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-1-isopropyl-3-methyl-6-(6-(4-methylpiperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide 推薦供應(yīng)商 |
|
|
建議您優(yōu)先選擇企業(yè)會員,我們對企業(yè)會員產(chǎn)品有嚴(yán)格審核。 |
|
|